ArticleFrontiers in oncology2021

One to Two Cycles of Consolidation Chemotherapy With Capecitabine After Neoadjuvant Chemoradiotherapy Does Not Benefit Low-Risk Patients With Locally Advanced Middle-Low Rectal Cancer.

Xueqing Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.